Vor Biopharma hits Wall Street with $177M IPO

Retrieved on: 2021-02-05 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Vor Biopharma hits Wall Street with $177M IPO. View article details on hiswai:

Excerpt

En route to its first human trial, Vor Biopharma raised $177 million in its Nasdaq debut. The IPO comes seven months after a $110 million venture ...

Article found on: www.fiercebiotech.com